The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Atypical Kinetic Profiles in Drug Metabolism Reactions
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Human Hepatic Cytochromes P450 Involved in Drug Metabolism
Wrighton, S. A., & Stevens, J. C. (1992) · Critical Reviews in Toxicology · doi:10.3109/10408449209145319 · Cited by 944
Korzekwa, K. R., Krishnamachary, N., Shou, M., Ogai, A., Parise, R. A., Rettie, A. E., Gonzalez, F. J., & Tracy, T. S. (1998) · Biochemistry · doi:10.1021/bi9715627 · Cited by 511
Self-citationHouston, J. B., & Kenworthy, K. E. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15358-5 · Cited by 389
Cooperativity in Oxidations Catalyzed by Cytochrome P450 3A4
Ueng, Y.-F., Kuwabara, T., Chun, Y.-J., & Guengerich, F. P. (1997) · Biochemistry · doi:10.1021/bi962359z · Cited by 383
Wiebel, F. J., Leutz, J. C., Diamond, L., & Gelboin, H. V. (1971) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(71)90456-5 · Cited by 369
Shou, M., Grogan, J., Mancewicz, J. A., Krausz, K. W., Gonzalez, F. J., Gelboin, H. V., & Korzekwa, K. R. (1994) · Biochemistry · doi:10.1021/bi00187a009 · Cited by 351
In Vitro Glucuronidation Using Human Liver Microsomes and The Pore-Forming Peptide Alamethicin
Fisher, M. B., Campanale, K., Ackermann, B. L., VandenBranden, M., & Wrighton, S. A. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15100-8 · Cited by 343
CYP3A4 drug interactions: correlation of 10 in vitro probe substrates
Kenworthy, Bloomer, Clarke, & Houston (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00073.x · Cited by 336
Stresser, D. M., Blanchard, A. P., Turner, S. D., Erve, J. C. L., Dandeneau, A. A., Miller, V. P., & Crespi, C. L. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)13672-0 · Cited by 273
Human Cytochrome P-450 3A4: In Vitro Drug-Drug Interaction Patterns Are Substrate-Dependent
Wang, R. W., Newton, D. J., Liu, N., Atkins, W. M., & Lu, A. Y. H. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15374-3 · Cited by 240
Harlow, G. R., & Halpert, J. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6636 · Cited by 228
Andersson, T., Miners, J., Veronese, M., & Birkett, D. (1994) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1994.tb04336.x · Cited by 225
Elucidation of Distinct Ligand Binding Sites for Cytochrome P450 3A4
Hosea, N. A., Miller, G. P., & Guengerich, F. P. (2000) · Biochemistry · doi:10.1021/bi992765t · Cited by 219
Yamazaki, H., Johnson, W. W., Ueng, Y.-F., Shimada, T., & Guengerich, F. P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.44.27438 · Cited by 194
Further Characterization of the Expression in Liver and Catalytic Activity of CYP2B6
Ekins, S., Vandenbranden, M., Ring, B. J., Gillespie, J. S., Yang, T. J., Gelboin, H. V., & Wrighton, S. A. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37719-5 · Cited by 178
Kenworthy, K. E., Clarke, S. E., Andrews, J., & Houston, J. B. (2001) · PubMed · Cited by 160
Tang, C., Shou, M., Mei, Q., Rushmore, T. H., & Rodrigues, A. D. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39255-9 · Cited by 159
Substrate inhibition kinetics for cytochrome P450-catalyzed reactions.
Lin, Y., Lü, P., Tang, C., Mei, Q., Sandig, G., Rodrigues, A. D., Rushmore, T. H., & Shou, M. (2001) · PubMed · Cited by 154
Roles of Human Hepatic Cytochrome P450s 2C9 and 3A4 in the Metabolic Activation of Diclofenac
Tang, W., Stearns, R. A., Wang, R. W., Chiu, S.-H. L., & Baillie, T. A. (1999) · Chemical Research in Toxicology · doi:10.1021/tx9802217 · Cited by 153
Shou, M., Qin, M. E. I., ETTORE, J. M. W., Dai, R., Baillie, T. A., & Rushmore, T. H. (1999) · Biochemical Journal · doi:10.1042/bj3400845 · Cited by 148
Wiebel, F. J., & Gelboin, H. V. (1975) · Biochemical Pharmacology · doi:10.1016/0006-2952(75)90028-3 · Cited by 145
SCHWAB, G. E., Raucy, J. L., & Johnson, E. F. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13354-3 · Cited by 145
Wang, R. W., Newton, D. J., Scheri, T. D., & Lu, A. Y. H. (1997) · PubMed · Cited by 141
Interaction of the enantiomers of fluoxetine and norfluoxetine with human liver cytochromes P450.
Stevens, J. C., & Wrighton, S. A. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38409-0 · Cited by 137
Differential Mechanisms of Cytochrome P450 Inhibition and Activation by α-Naphthoflavone
Koley, A. P., Buters, J., Robinson, R. C., Markowitz, A., & Friedman, F. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3149 · Cited by 132
Cytochrome P450 2E1 is the Principal Catalyst of Human Oxidative Halothane Metabolism in Vitro
Spracklin, D. K., Hankins, D. C., Fisher, J. M., et al. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36603-0 · Cited by 122
Enzyme Kinetics of Cytochrome P450-Mediated Reactions
Shou, M., Lin, Y. J., Lü, P., Tang, C., Mei, Q., Cui, D., Tang, W., Ngui, J. S., Lin, C., Singh, R., et al. (2005) · Current Drug Metabolism · doi:10.2174/1389200013338784 · Cited by 121
Human cytochrome P450 3A (CYP3A) mediated midazolam metabolism
enp, J. M., Hall, S. D., Ring, B. J., Strom, S. C., & Wrighton, S. A. (1998) · Pharmacogenetics · doi:10.1097/00008571-199804000-00007 · Cited by 118
Shou, M., Dai, R., Cui, D., Korzekwa, K. R., Baillie, T. A., & Rushmore, T. H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008799200 · Cited by 117
Domanski, T. L., Liu, J., Harlow, G. R., & Halpert, J. R. (1998) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1997.0525 · Cited by 115
Dual Role of Human Cytochrome P450 3A4 Residue Phe-304 in Substrate Specificity and Cooperativity
Domanski, T. L., He, Y.-A., Harlow, G. R., & Halpert, J. R. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39272-9 · Cited by 108
Hutzler, J. M., Hauer, M. J., & Tracy, T. S. (2001) · PubMed · Cited by 105
Self-citationAtkins, W. M., Wang, R. W., & Lu, A. Y. H. (2001) · Chemical Research in Toxicology · doi:10.1021/tx0002132 · Cited by 100
Ring, B. J., Eckstein, J. A., Gillespie, J. S., et al. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29631-2 · Cited by 96
Guryev, O. L., Gilep, A. A., Usanov, S. A., & Estabrook, R. W. (2001) · Biochemistry · doi:10.1021/bi002305w · Cited by 90
Witherow, L. E., & Houston, J. B. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)34868-2 · Cited by 83
Studies on the mechanism of activation of microsomal benzo[a]pyrene hydroxylation by flavonoids.
Huang, M., Chang, R. L., Fortner, J. G., & Conney, A. H. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)69067-8 · Cited by 81
Tracy, T. S., Hutzler, J. M., Haining, R. L., Rettie, A. E., Hummel, M. A., & Dickmann, L. J. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.4.385 · Cited by 81
Self-citationIn vitro and in vivo activation of oxidative drug metabolism by flavonoids.
Lasker, J. M., Huang, M. T., & Conney, A. H. (1984) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21801-8 · Cited by 80
Microsomal Binding of Amitriptyline: Effect on Estimation of Enzyme Kinetic Parameters In Vitro
Venkatakrishnan, K., Moltke, L. L., Obach, R. S., & Greenblatt, D. J. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39241-9 · Cited by 76
Cytochrome P450 3A4-Mediated Interaction of Diclofenac and Quinidine
Ngui, J. S., Tang, W., Stearns, R. A., et al. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15184-7 · Cited by 75
Interaction of Diclofenac and Quinidine in Monkeys: Stimulation of Diclofenac Metabolism
Tang, W., Stearns, R. A., Kwei, G. Y., Iliff, S. A., Miller, R. R., Egan, M. A., Yu, N. X., Dean, D. C., Kumar, S., Shou, M., et al. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35211-5 · Cited by 73
Ludwig, E., Schmid, J., Beschke, K., & Thomas, E. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)34860-8 · Cited by 61
Triazolam Substrate Inhibition
Schrag, M. L., & Wienkers, L. C. (2001) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0667-6_56 · Cited by 61
Szklarz, G. D., & Halpert, J. R. (1998) · PubMed · Cited by 56
Miller, G. P., & Guengerich, F. P. (2001) · Biochemistry · doi:10.1021/bi010402z · Cited by 53
Lu, P., Lin, Y. J., Rodrigues, A. D., Rushmore, T. H., Baillie, T. A., & Shou, M. (2001) · PubMed · Cited by 48
Topological Alteration of the CYP3A4 Active Site by the Divalent Cation Mg2+
Schrag, M. L., & Wienkers, L. C. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0026-895x(24)12050-0 · Cited by 46
Schrag, M. L., & Wienkers, L. C. (2001) · PubMed · Cited by 37
Palamanda, J. R., Feng, W.-W., Lin, C., & Nomeir, A. A. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15001-5 · Cited by 34
Oda, Y., & Kharasch, E. D. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29553-7 · Cited by 33
Oda, Y., & Kharasch, E. D. (2001) · PubMed · Cited by 31
Activation of phenacetinO-deethylase activity byα-naphthoflavone in human liver microsomes
Nakajima, M., Kobayashi, K., Oshima, K., Shimada, N., Tokudome, S., Chiba, K., & Yokoi, T. (1999) · Xenobiotica · doi:10.1080/004982599238137 · Cited by 25
Cited by
Fundamentals of Enzyme Kinetics
Seibert, E., & Tracy, T. S. (2014) · Methods in Molecular Biology · doi:10.1007/978-1-62703-758-7_2 · Cited by 370
Self-citationCLINICAL AND TOXICOLOGICAL RELEVANCE OF CYP2C9: Drug-Drug Interactions and Pharmacogenetics
Rettie, A. E., & Jones, J. P. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095821 · Cited by 254
Bianco, A. C., Anderson, G., Forrest, D., Galton, V. A., Gereben, B., Kim, B. W., Kopp, P. A., Liao, X. H., Obregon, M. J., Peeters, R. P., et al. (2014) · Thyroid · doi:10.1089/thy.2013.0109 · Cited by 205
Davies, B. J., Coller, J. K., Somogyi, A. A., Milne, R. W., & Sallustio, B. C. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.012252 · Cited by 25
Metadata
- Authors
- Hutzler, J. M., & Tracy, T. S.
- Venue
- Drug Metabolism and Disposition
- Publisher
- Elsevier BV
- Published
- 2002-04
- Volume
- 30
- Issue
- 4
- Pages
- 355-362
- ISSN
- 0090-9556 (ISSN-L)
- OpenAlex
- W2164945771
- Cited by
- 261
- References
- 54
- FWCI
- 7.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.